James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $559.58 ($5.7M) on 2026-05-26, disclosed to the SEC on 2026-05-27.
Scheduled sale ($5.7M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $559.58 | 25 | $14K | 0.2% |
| 2 | $561.21 | 135 | $76K | 1.3% |
| 3 | $564.02 | 280 | $158K | 2.8% |
| 4 | $566.37 | 240 | $136K | 2.4% |
| 5 | $567.36 | 520 | $295K | 5.1% |
| 6 | $568.54 | 1,040 |
| $591K |
| 10.3% |
| 7 | $569.79 | 760 | $433K | 7.6% |
| 8 | $570.92 | 700 | $400K | 7.0% |
| 9 | $571.93 | 860 | $492K | 8.6% |
| 10 | $572.70 | 440 | $252K | 4.4% |
| 11 | $574.13 | 281 | $161K | 2.8% |
| 12 | $575.24 | 809 | $465K | 8.1% |
| 13 | $576.21 | 1,221 | $704K | 12.3% |
| 14 | $577.13 | 1,929 | $1.1M | 19.4% |
| 15 | $578.12 | 760 | $439K | 7.7% |
| Total | $572.94 avg | 10,000 | $5.7M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |